Catalog No.
VQB91701
Species reactivity
Dog
Host species
Dog
Isotype
IgG2, kappa
Clonality
Monoclonal
Applications
ELISA, Neutralization
Target
Beta-nerve growth factor, NGFB, Beta-NGF, NGF
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
F1PDQ3
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Iv0216
Note
For research use only. Not suitable for clinical or therapeutic use.
An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells., PMID:1655809
Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation., PMID:8994439
Immunological and chemical characterization of glycoproteins in IEF fractions of Blastomyces dermatitidis yeast lysate antigen., PMID:9375492
Nerve growth factor and corneal wound healing in dogs., PMID:15862170
A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone., PMID:16230406
Co-expression of nerve growth factor and p75NGFR in the inferior alveolar nerve after mandibular distraction osteogenesis., PMID:18346878
Investigating TrkA expression in canine appendicular osteosarcoma., PMID:18638015
In vitro and in vivo gene therapy with CMV vector-mediated presumed dog beta-nerve growth factor in pyridoxine-induced neuropathy dogs., PMID:19043311
Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain., PMID:21048122
Effects of high thoracic epidural anesthesia on atrial electrophysiological characteristics and sympathetic nerve sprouting in a canine model of atrial fibrillation., PMID:21318296
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain., PMID:21907491
Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor., PMID:23249404
A fully caninised anti-NGF monoclonal antibody for pain relief in dogs., PMID:24206926
Canine Brief Pain Inventory scores for dogs with osteoarthritis before and after administration of a monoclonal antibody against nerve growth factor., PMID:24866508
A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain., PMID:25926287
In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats., PMID:27306920
A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study., PMID:27334504
Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats., PMID:30368458
Expression and Prognostic Significance of Neurotrophins and Their Receptors in Canine Mammary Tumors., PMID:32351171
Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:34391918
The expression of nerve growth factor in healthy and inflamed equine chondrocytes analysed by capillary western immunoassay., PMID:36029605
Re: Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:38885831
Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus., PMID:39991224
For research use only. Not for human or drug use.
